Harry Kraft is a European and Belgian Patent Attorney with over 20 years experience in the life science industry. Prior to his current role as head of IP at Biocartis, Harry was a Senior Patent Attorney at Ablynx, a pharmaceutical company with proprietary Nanobody® technology. He also has 11 years proficiency in private practice at De Clercq & Partners, where he was involved in providing the full range of patent services as well as schooling personnel in IP matters. He was trained as a molecular biologist and occupied a post-doc position at the VIB-department Cell growth, differentiation and development of Prof. Dr. D. Huylebroeck at the KU Leuven.